tiprankstipranks
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market
MLTX
MoonLake Immunotherapeutics
RESEARCH TOOLSreports
Want to see MLTX full AI Analyst Report?

MoonLake Immunotherapeutics (MLTX) Income Statement

648 Followers

MoonLake Immunotherapeutics Income Statement

Last quarter (Q4 2025), MoonLake Immunotherapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, MoonLake Immunotherapeutics's net income was $-62.43M. See MoonLake Immunotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.62M$ 0.00$ 0.00$ 0.00$ -4.97K
Operating Expenses
$ 242.22M$ 143.09M$ 54.12M$ 65.06M$ 53.57M
Depreciation and Amortization
$ 2.62M$ 1.38M$ 370.32K$ 164.78K$ 4.97K
EBITDA
$ -219.85M$ -141.71M$ -53.75M$ -64.90M$ -53.63M
Operating Income
$ -244.83M$ -143.09M$ -54.12M$ -65.06M$ -53.58M
Other Income/Expenses
$ 15.12M$ 22.13M$ 10.14M$ 591.73K$ -61.85K
Pretax Income
$ -229.71M$ -120.96M$ -43.98M$ -64.47M$ -53.64M
Net Income
$ -227.32M$ -118.94M$ -36.01M$ -49.97M$ -53.64M
Per Share Metrics
Basic EPS
$ -3.53$ -1.89$ -0.73$ -2.20$ -1.45
Diluted EPS
$ -3.53$ -1.89$ -0.73$ -2.20$ -1.45
Weighted Average Shares Outstanding
 64.46M 62.87M 49.12M 29.36M 36.93M
Weighted Average Shares Outstanding (Diluted)
 64.46M 62.87M 49.12M 29.36M 36.93M
Currency in USD

MoonLake Immunotherapeutics Earnings and Revenue History